Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lynx Bioconsulting
San Diego, California, United Statespmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
LynxBio leverages a proprietary ex vivo disease biology and multiomics platform to generate data-driven insights for the discovery and development of new therapies in immuno-oncology. No clinical results or late-stage programs are publicly disclosed as of now.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Multiomics platform (enables work with various modalities; specific therapeutic modalities not explicitly listed)
- Industry
- Drug Discovery Services
02
Partnerships
Collaborates with leading biopharma and technology companies for early-stage research/discovery partnershipsIncubated at J&J JLABS (Johnson & Johnson Innovation Labs)
Beyond the preview
Go deeper on Lynx Bioconsulting.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lynx Bioconsulting.